[go: up one dir, main page]

CR8889A - Derivados de n-(1h-indolil)- 1h-indol-2- carboxamidas, su preparacion y su aplicacion en terapeutica - Google Patents

Derivados de n-(1h-indolil)- 1h-indol-2- carboxamidas, su preparacion y su aplicacion en terapeutica

Info

Publication number
CR8889A
CR8889A CR8889A CR8889A CR8889A CR 8889 A CR8889 A CR 8889A CR 8889 A CR8889 A CR 8889A CR 8889 A CR8889 A CR 8889A CR 8889 A CR8889 A CR 8889A
Authority
CR
Costa Rica
Prior art keywords
indolil
carboxamids
indol
therapeutics
derivatives
Prior art date
Application number
CR8889A
Other languages
English (en)
Inventor
Laurent Dubois
Yannick Evanno
Luc Even
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of CR8889A publication Critical patent/CR8889A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Psychiatry (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La invencion se refiere a compuestos de formula general ( I ): en la que X1,X2,X3,X4,Z1,Z2,Z3,Z4 y Z5 representan, independientemente uno del otro un atomo de hidrogeno o de halogeno o un grupo alquilo C1-C6, cicloalquilo C3-C7, fluoroalquilo C1-C6.
CR8889A 2004-08-05 2007-02-01 Derivados de n-(1h-indolil)- 1h-indol-2- carboxamidas, su preparacion y su aplicacion en terapeutica CR8889A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0408652A FR2874015B1 (fr) 2004-08-05 2004-08-05 Derives de n-(1h-indolyl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
CR8889A true CR8889A (es) 2007-10-01

Family

ID=34950701

Family Applications (1)

Application Number Title Priority Date Filing Date
CR8889A CR8889A (es) 2004-08-05 2007-02-01 Derivados de n-(1h-indolil)- 1h-indol-2- carboxamidas, su preparacion y su aplicacion en terapeutica

Country Status (37)

Country Link
US (3) US7384969B2 (es)
EP (1) EP1776340B1 (es)
JP (1) JP5100381B2 (es)
KR (1) KR101215162B1 (es)
CN (1) CN101010297B (es)
AR (1) AR050283A1 (es)
AT (1) ATE416160T1 (es)
AU (1) AU2005279085B2 (es)
BR (1) BRPI0513087A (es)
CA (1) CA2576727C (es)
CR (1) CR8889A (es)
CY (1) CY1108816T1 (es)
DE (1) DE602005011450D1 (es)
DK (1) DK1776340T3 (es)
EA (1) EA011714B1 (es)
EC (1) ECSP077215A (es)
ES (1) ES2318542T3 (es)
FR (1) FR2874015B1 (es)
HR (1) HRP20090101T3 (es)
IL (1) IL180911A (es)
MA (1) MA28845B1 (es)
ME (1) ME01663B (es)
MX (1) MX2007001436A (es)
MY (1) MY139286A (es)
NO (1) NO340060B1 (es)
NZ (1) NZ552924A (es)
PE (1) PE20060557A1 (es)
PL (1) PL1776340T3 (es)
PT (1) PT1776340E (es)
RS (1) RS50853B (es)
SI (1) SI1776340T1 (es)
TN (1) TNSN07041A1 (es)
TW (1) TWI360538B (es)
UA (1) UA90483C2 (es)
UY (1) UY29046A1 (es)
WO (1) WO2006024776A1 (es)
ZA (1) ZA200700999B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2874015B1 (fr) * 2004-08-05 2006-09-15 Sanofi Synthelabo Derives de n-(1h-indolyl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
FR2880625B1 (fr) 2005-01-07 2007-03-09 Sanofi Aventis Sa Derives de n-(heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
FR2888847B1 (fr) 2005-07-22 2007-08-31 Sanofi Aventis Sa Derives de n-(heteriaryl)-1-heteorarylalkyl-1h-indole-2- carboxamides, leur preparation et application en therapeutique
PE20080145A1 (es) 2006-03-21 2008-02-11 Janssen Pharmaceutica Nv Tetrahidro-pirimidoazepinas como moduladores de trpv1
FR2910473B1 (fr) 2006-12-26 2009-02-13 Sanofi Aventis Sa Derives de n-(amino-heteroaryl)-1h-pyrrolopyridine-2- carboxamides, leur preparation et leur application en therapeutique.
FR2911604B1 (fr) 2007-01-19 2009-04-17 Sanofi Aventis Sa Derives de n-(heteroaryl-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
KR20100066422A (ko) * 2007-08-10 2010-06-17 하. 룬트벡 아크티에 셀스카브 헤테로아릴 아미드 유사체
CL2008003749A1 (es) 2007-12-17 2010-01-15 Janssen Pharmaceutica Nv Compuestos derivados de imidazol, oxazol, y tiazol pirimidina, moduladores de trpv1, proceso de preparacion, composicion farmaceutica y su uso en el tratamiento de enfermedades, trastornos o condicion de dolor, prurito, artritis, tos, asma, trastorno del oido interno y enfermedad inflamatoria intestinal, entre otras.
FR2926555B1 (fr) 2008-01-22 2010-02-19 Sanofi Aventis Derives bicycliques de carboxamides azabicycliques, leur preparation et leur application en therapeutique
FR2926556B1 (fr) * 2008-01-22 2010-02-19 Sanofi Aventis Derives de carboxamides n-azabicycliques, leur preparation et leur application en therapeutique
FR2926554B1 (fr) 2008-01-22 2010-03-12 Sanofi Aventis Derives de carboxamides azabicycliques, leur preparation et leur application en therapeutique
US20100210682A1 (en) * 2009-02-19 2010-08-19 Abbott Laboratories Repeated Dosing of TRPV1 Antagonists
FR3007850B1 (fr) 2013-06-28 2015-07-17 Probayes Systeme de prediction de temperature

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5846990A (en) * 1995-07-24 1998-12-08 Bristol-Myers Squibb Co. Substituted biphenyl isoxazole sulfonamides
KR100508200B1 (ko) * 1996-02-13 2005-12-16 아보트 러보러터리즈 엔도텔린길항제로서의벤조-1,3-디옥솔릴-및벤조푸라닐치환된피롤리딘유도체및이를함유하는약제
TR200101233T2 (tr) * 1997-08-04 2002-06-21 Abbott Laboratories Endotelin antagonistleri.
EP1314733A1 (en) * 2001-11-22 2003-05-28 Aventis Pharma Deutschland GmbH Indole-2-carboxamides as factor Xa inhibitors
CA2468544A1 (en) * 2001-12-10 2003-06-19 Amgen Inc. Vanilloid receptor ligands
US7053088B2 (en) * 2002-05-22 2006-05-30 Amgen Inc. Vanilloid receptor ligands and their use in treatments
EP1578418A2 (en) * 2002-12-20 2005-09-28 Bayer HealthCare AG Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
ES2337254T3 (es) 2003-02-14 2010-04-22 Glaxo Group Limited Derivados de carboxamida.
US7544803B2 (en) * 2004-01-23 2009-06-09 Amgen Inc. Vanilloid receptor ligands and their use in treatments
FR2874015B1 (fr) * 2004-08-05 2006-09-15 Sanofi Synthelabo Derives de n-(1h-indolyl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
FR2880625B1 (fr) * 2005-01-07 2007-03-09 Sanofi Aventis Sa Derives de n-(heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
ECSP077215A (es) 2007-02-28
MX2007001436A (es) 2007-04-19
TWI360538B (en) 2012-03-21
JP5100381B2 (ja) 2012-12-19
ME01663B (me) 2010-08-31
PT1776340E (pt) 2009-02-20
US7582671B2 (en) 2009-09-01
IL180911A0 (en) 2007-07-04
FR2874015A1 (fr) 2006-02-10
PL1776340T3 (pl) 2009-05-29
WO2006024776A1 (fr) 2006-03-09
US20090286846A1 (en) 2009-11-19
UA90483C2 (uk) 2010-05-11
EA200700400A1 (ru) 2007-06-29
UY29046A1 (es) 2006-03-31
EP1776340A1 (fr) 2007-04-25
ATE416160T1 (de) 2008-12-15
HK1110308A1 (en) 2008-07-11
DE602005011450D1 (de) 2009-01-15
IL180911A (en) 2011-06-30
TNSN07041A1 (fr) 2008-06-02
NO340060B1 (no) 2017-03-06
CA2576727C (fr) 2013-11-26
AU2005279085B2 (en) 2011-06-16
US20070149602A1 (en) 2007-06-28
JP2008509113A (ja) 2008-03-27
KR20070044000A (ko) 2007-04-26
AU2005279085A1 (en) 2006-03-09
US7384969B2 (en) 2008-06-10
CN101010297B (zh) 2011-07-27
RS50853B (sr) 2010-08-31
NZ552924A (en) 2010-08-27
DK1776340T3 (da) 2009-04-06
KR101215162B1 (ko) 2012-12-24
CA2576727A1 (fr) 2006-03-09
US7781477B2 (en) 2010-08-24
CN101010297A (zh) 2007-08-01
MA28845B1 (fr) 2007-09-03
FR2874015B1 (fr) 2006-09-15
EA011714B1 (ru) 2009-04-28
ES2318542T3 (es) 2009-05-01
ZA200700999B (en) 2008-06-25
AR050283A1 (es) 2006-10-11
US20080227843A1 (en) 2008-09-18
CY1108816T1 (el) 2014-04-09
NO20071198L (no) 2007-03-02
SI1776340T1 (sl) 2009-04-30
PE20060557A1 (es) 2006-08-07
HRP20090101T3 (en) 2009-03-31
BRPI0513087A (pt) 2008-04-22
EP1776340B1 (fr) 2008-12-03
MY139286A (en) 2009-09-30
TW200616954A (en) 2006-06-01

Similar Documents

Publication Publication Date Title
CR8889A (es) Derivados de n-(1h-indolil)- 1h-indol-2- carboxamidas, su preparacion y su aplicacion en terapeutica
CR9590A (es) Derivados de n-(heteroaril)-1-heteroarilalquil-1h-indol-2-carboxamida su prepracion y su aplicacion en terapeutica
CR11546A (es) Derivados de carboxamidas azabiciclicas, su preparacion y su aplicacion en terapeutica
NO20082090L (no) Pyridopyrimidinoninhibitorer av P13K alfa
MA31906B1 (fr) Inhibiteurs de la replication du virus de limmunodeficience humaine
NO20083694L (no) Bruk av rylener som markorer for vaesker
CO6150146A2 (es) Derivados de n-(amino-heteroaril)-1h-indol-2-carboxamidas su preparacion y su aplicacion en terapeutica
ATE433447T1 (de) Pyrimiidinverbindungen
NO20070557L (no) Ftalazinderivater som PARP-inhibitorer
GT200600134A (es) Compuestos novedosos de derivados de aminosulfonilo
CO6220974A2 (es) Derivados de indol 2-carboxamidas y de azaindol 2- carboxamidas sustituidos con un grupo silanilo su preparacion y su aplicacion en terapeutica
NO20075647L (no) Kjemiske forbindelser
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
NO20081724L (no) Stabil farmasoytisk sammensetning omfattende et pyrimidin-sulfamid
DK2134691T3 (da) Quinolinonderivativer som parp- og tank-inhibitorer
NO20090628L (no) Pyridizinon derivativater
NO20076145L (no) Ureadeviater, fremgangsmater for deres fremstilling og anvendelse derav
ATE495176T1 (de) Spiroindolinon-derivate
ECSP088677A (es) Piperazinas y piperidinas como potenciadores 157 del mglur5
EA200800546A1 (ru) Бензимидазолтиофеновые соединения в качестве ингибиторов polo-подобных киназ (plk)
SE0403171D0 (sv) New compounds
PA8663901A1 (es) Derivados del (1,5-difenil-1h-pirazol-3-il)oxadiazol, su prepararacion y su aplicacion en terapéutica
NO20063944L (no) Piperidinylkarbonyl-pyrrolidiner og deres anvendelse som melanokortinagonister
UY29327A1 (es) Derivados de n-(heteroaril)- 1 h- indol-2-carboxamidas, su preparacion y su aplicacion en terapeutica
DE602004018811D1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren